CEO William “Bill” Hartman, Premier Biomedical, Interviewed on Stu Taylor Radio Show
OncBioMune Pharmaceuticals CEO, Dr. Jon Head, Updates Progress of their Prostate Cancer Vaccine
Premier Biomedical Anti-Cancer Antibody Outperforms Leading Multi-Billion Dollar Commercial Cancer Treatments in Initial Head-to-Head Testing at a Major University
James McGorry, CEO with Biostage, Inc., Explains their Cellframe™ Technology Platform with Uptick Network
Wally Klemp, with Moleculin Biotech, Inc. (MBRX), discusses on Uptick Network their new treatment for Second-Line Leukemia Patients
Premier Biomedical Confirms Consolidation of Debt
Premier Biomedical Announces the Appointment of Dr. James Frincketo Chief Technical Officer Position
Uptick Network – Interview with CEO Fred Ors with ImmunoVaccine Inc.
Uptick Network – Interview with CEO James Katzaroff with Advanced Medical Isotopes Corporation
Premier Biomedical/UTEP Demonstrate New Anti-Cancer Immunotherapy Drug; May Compete Against Best of Big Pharma Drugs
Premier Biomedical, Inc. Cancer Immunotherapy Research Highlights to be Presented at AACR Conference
Uptick Network – Interview with CEO Ian Dixon from UMAX
CEO Letter, April, 2016
Innovus Pharma Announces the Availability of Androferti® in the U.S.
Premier Biomedical, Inc. Engages Agent to Identify Suitable Joint Venture Partners in China and Europe